Inviting CSR funds of Indian Industries for S & T interventions of CSIR-CIMAP to augment socio-economic benefit to the society

The Government of India has allowed corporate India to use its mandatory Corporate Social Responsibility (CSR) spending for investments in publicly-funded incubators and contribute to research efforts in science, technology, medicine and engineering at major institutions and bodies. This 2% CSR fund of average net profit of companies over the last three years can be spent on incubators funded by Central or State Government or any agency or Public Sector Undertaking of Central or State Government, and, making contributions to public-funded Universities, IITs, National Laboratories and Autonomous Bodies (established under the auspices of ICAR, ICMR, CSIR, DAE, DRDO, DST, MEITY) engaged in conducting research in science, technology, engineering and medicine aimed at promoting Sustainable Development Goals (SDGs).

It is a matter of pride for the business entities to participate in the national development by investing in an ethical and transparent way to contribute positively towards the growth as well as the welfare of the society. This investment in national development plays a critical role in enabling society to operate effectively. Considering that we are presently in a knowledge-based society, an investment towards R & D as well as S & T interventions is expected to lead to a very high degree of social empowerment, economic development and environmental compliance.

CSIR-CIMAP invited CSR funds of corporate for the socio-economic benefit of the society in the medicinal and aromatic plants research domain.